XTX Topco’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $716K | Buy |
+49,690
| New | +$716K | 0.03% | 866 |
|
|
2025
Q1 | – | Sell |
-22,697
| Closed | -$120K | – | 3262 |
|
|
2024
Q4 | $120K | Buy |
+22,697
| New | +$120K | 0.01% | 1717 |
|
|
2024
Q1 | – | Sell |
-17,265
| Closed | -$24.7K | – | 2422 |
|
|
2023
Q4 | $24.7K | Buy |
17,265
+3,644
| +27% | +$5.21K | 0.01% | 1340 |
|
|
2023
Q3 | $19.9K | Buy |
+13,621
| New | +$19.9K | ﹤0.01% | 1376 |
|
|
2022
Q2 | – | Sell |
-30,998
| Closed | -$76K | – | 1155 |
|
|
2022
Q1 | $76K | Buy |
+30,998
| New | +$76K | 0.03% | 548 |
|
|
2021
Q3 | – | Sell |
-12,528
| Closed | -$124K | – | 1120 |
|
|
2021
Q2 | $124K | Buy |
+12,528
| New | +$124K | 0.04% | 632 |
|